Stay updated on Pembrolizumab Combo in Metastatic Colorectal Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic Colorectal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Metastatic Colorectal Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page revision label was updated to Revision: v3.3.4 and the previous Revision: v3.3.3 was removed. This is a metadata update and does not modify study content.
    Difference
    0.1%
    Check dated 2026-01-15T10:48:03.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    The page now lists a New York location under Locations, expanding visibility of where the study is conducted. The previous 'New York Locations' entry has been removed and the revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-17T20:06:09.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    Results have been posted, including the number of participants with response and toxicity data, along with associated results submission dates. A PDF of the Study Protocol and Statistical Analysis Plan has been added under Study Documents.
    Difference
    1%
    Check dated 2025-12-10T19:37:34.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    Added a note clarifying that publications are automatically filled from PubMed and may not all relate to the study. Revision updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T13:55:41.000Z thumbnail image
  8. Check
    59 days ago
    Change Detected
    Summary
    The banner about a lapse in government funding that previously appeared on the page has been removed, which does not affect the study information displayed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:20:36.000Z thumbnail image
  9. Check
    73 days ago
    Change Detected
    Summary
    The page content appears unchanged; the Study Details page for NCT02437071 and its sections (Overview, Eligibility Criteria, Study Plan, and Interventions) remain the same.
    Difference
    0.4%
    Check dated 2025-11-03T21:26:22.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Metastatic Colorectal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic Colorectal Cancer Clinical Trial page.